Hyperparathyroidism and long-term lithium therapy - A cross-sectional study and the effect of lithium withdrawal

Journal of Internal Medicine

Volumn 240, Issue 6, 1996, Pages 357-365

  Bendz, H ^a   Sjodin I ^b   Toss, G ^b   Berglund, K ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c Västmanland Hospital Vasteras   (Sweden)

Author keywords

Epidemiology; Hypercalcaemia; Hyperparathyroidism; Kidney function; Lithium toxicity

Indexed keywords

LITHIUM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; INCIDENCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RELAPSE;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; INCIDENCE; KIDNEY FAILURE, CHRONIC; LITHIUM; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PREVALENCE; SUBSTANCE WITHDRAWAL SYNDROME; SWEDEN;

EID: 0030478888     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.28864000.x     Document Type: Article

References (44)

1. Malette LE. Acute and chronic effects of lithium on human calcium metabolism. Lithium 1991; 2: 209-26.
2. Mellerup ET, Plenge P, Ziegler R, Rafaelsen OJ. Lithium effects on calcium metabolism in rats. Int Pharmacopsychiat 1970; 5: 258-64.
3. Garfinkel PE, Ezrin C, Stancer HC. Hypothyroidism and hyperparathyroidism associated with lithium. Lancet 1973; 2: 331-2.
4. Christiansen C, Baastrup PC, Lindgreen P, Transboel I. Endocrine effects of lithium: II. 'Primary' hyperparathyroidism. Acta Endocrinol 1978; 88: 528-34.
5. Christiansen C, Baastrup PC, Transboel I. Development of 'primary' hyperparathyroidism during lithium therapy: longitudinal study. Neuropsychobiol 1980; 6: 280-3.
6. Nordenström J, Strigård K, Perbeck L, Willems J, Bågedahl-Strindlund M, Linder J. Hyperparathyroidism associated with treatment of manic-depressive disorders by lithium. Eur J Surg 1992; 158: 207-11.
7. Bendz H, Aurell M, Balldin J, Mathé AA, Sjödin I. Kidney damage in long-term lithium patients. A cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant 1994; 9: 1250-4.
8. Bendy, H. Sjödin I, Aurell M. Renal function on and off lithium in patients who have been treated with lithium for 15 years or more - a controlled, prospective lithium withdrawal study. Accepted for publication in Nephrol Dial Transplant 1996; 11: 457-60.
9. Nussbaum S. Immunometric assays of parathyroid hormone in the diagnosis of hypercalcemic individuals. Clin Chem 1991; 37: 142-3.
10. Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271-4.
11. 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest 1981; 41: 611-6.
12. Delin K, Aurell M, Ewald J. Urinary concentration test with desmopressin. Br Med J 1978; 1: 757-8.
13. Tryding N, Berg B, Ekman S, Nilsson J-E, Sterner G, Harris A. DDAVP-test for renal concentration capacity. Age-related reference intervals. Scand J Urol Nephrol 1988; 22: 141-5.
14. Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980; 302: 189-93.
15. Christensson T, Hellström K, Wengle B, Alveryd A, Wikland B. Prevalence of hypercalcemia in a health screening in Stockholm. Acta Med Scand 1976; 200: 131-7.
16. Palmér M, Jakobsson S. Åkerström G, Ljunghall S. Prevalence of hypercalcaemia in a health survey; a 14-year follow-up study of serum calcium values. Europ J Clin Invest 1988; 18: 59-46.
17. Linder J, Levin K, Sääf J, Brismar K, Wetterberg L, Werner S. Influence of lithium treatment on calcium and magnesium in plasma and erythrocytes. Lithium 1995; 4: 115-23.
18. Christensson TAT. Lithium, hypercalcaemia, and hyperparathyroidism. Lancet 1976; ii: 144.
19. Cervie-Skinner SJ. Lithium-carbonate-induced hypercalcemia. West J Med 1977; 127: 527-8.
20. Prasad A. Chronic lithium intake and hyperparathyroidism. Eur J Pharmacol 1984; 27: 499-500.
21. Ananth J, Dubin SE. Lithium and symptomatic hyperparathyroidism. JR Soc Med 1983; 76: 1026-9.
22. Joborn C, Hetta J, Lind L, Rastad J, Åkerström G, Ljunghall S. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Surgery 1989; 105: 72-8.
23. Smigan L. Long-term lithium treatment. Some clinical, psychological and biological aspects. Acta Psychiatr Scand 1985; 71: 160-70.
24. Toffaletti J, McComb RB, Bowers GN Jr. Increase in dialyzable calcium associated with therapy with lithium. Clin Chem 1979; 25: 1806-9.
25. Mallette LE, Khouri K, Zengotita H, Hollis BW, Malini S. Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume. J Clin Endocrin Metab 1989; 68: 654-60.
26. Nordenström J, Elvius M, Bågedahl-Strindlund M, Zhao B, Törring O. Biochemical hyperparathyroidism and bone mineral status in patients treated long-term with lithium. Metabolism 1994; 43: 1-5.
27. Davis BM, Pfefferbaum A, Krutzik S, Davis KL. Lithium's effect on parathyroid hormone. Am J Psychiatry 1981; 138: 489-92.
28. Seely EW, Moore TJ, LeBoff MS, Brown EM. A single dose of lithium carbonate acutely elevates intact parathyroid hormone levels in humans. Acta Endocrinol 1989; 121: 174-6.
29. McHenry CR, Racke F, Meister M, Warnaka P, Sarasua M, Nemeth EF et al. Lithium effects on dispersed bovine parathyroid cells grown in tissue culture. Surgery 1991; 110: 1061-6.
30. 2+ in the modulation of secretion by parathyroid cells in vitro. J Biol Chem 1983; 258: 6288-92.
31. Brown EM. Lithium induces abnormal calcium-regulated PTH release in dispersed bovine parathyroid cells. J Clin Endocrinol Metab 1981; 52: 1046-8.
32. 2+-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-80.
33. Saxe AW, Gibson G. Lithium increases tritiated thymidine uptake by abnormal human parathyroid tissue. Surgery 1991; 110: 1067-77.
34. Saxe AW, Gibson G, Silveira E. Effects of long-term lithium infusion on normal parathyroid tissue. Surgery 1995; 117: 577-80.
35. Rabin PL, Evans DC. Exophtalmos and elevated thyroxine levels in association with lithium therapy. J Clin Psychiatry 1981; 42: 398-400.
36. Krivitzky A, Bentata-Pessayre M, Sarfati E, Gardin JP, Callard P, Delzant G. Lésions hypersécrétantes multiples des parathyroïdes au cours d'un traitement par le Lithium. Ann Med Interne 1986; 137: 118-22.
37. Feldman MG, Pachman JS. Surgical management of lithium-induced hypercalcemia. Conn Med 1990; 54: 614-5.
38. Ananth J, Wohl M, Zegers C, Remmel R. Hyperparathyroid adenoma with lithium therapy. Lithium 1991; 2: 54-7.
39. Labussière A-S, Delamare N, Brochier T, Dartevelle P, Christoforov B. Lithium, hyperparathyroïdie et adénome parathyroïdien. Ann Med Interne 1993; 144: 136-7.
40. Leutgeb U. Lithium and its effects on the endocrine system, bones and peripheral nerves - a current review. Fortschr Neurol Psychiatr 1995; 63: 149-61.
41. Palmér M, Adami H-O, Bergström R, Jakobsson S, Åkerström G, Ljunghall S. Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet 1987; i: 59-62.
42. Weiss NM, Robertson GL. Effect of hypercalcemia and lithium therapy on the osmoregulation of thirst and vasopressin secretion. In: Schrier RW ed. Vasopressin. New York: Raven Press, 1985; 281-9.
43. Stancer HC, Forbath N. Hyperparathyroidism, hypothyroidism and impaired renal function after 10-20 years of lithium treatment. Arch Int Med 1989; 149: 1042-5.
44. Paloyan E, Lawrence AM, Oslapas R, Jarosz H, Davis M, Ernst K et al. L'hyperparathyroïdie et la thyroïdite d'Hashimoto: coïncidence ou conséquence. Ann Chir 1990; 44: 376-7.